Antiarrhythmic drugs.
暂无分享,去创建一个
[1] R Lazzara,et al. Electrophysiologic basis for arrhythmias in ischemic heart disease. , 1984, The American journal of cardiology.
[2] K. Nademanee,et al. Antiarrhythmic Effects of Verapamil , 1983, Angiology.
[3] D. Shand,et al. Therapeutic Drug Monitoring of Antiarrhythmic Agents , 1982, Clinical pharmacokinetics.
[4] K. Nademanee,et al. Role of serum T4 and reversed T3 in monitoring antiarrhythmic efficacy and toxicity of amiodarone in resistant arrhythmias , 1981 .
[5] G. Wagner,et al. Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction. , 1980, Annals of internal medicine.
[6] N. Carliner,et al. Relation of ventricular premature beat suppression to serum quinidine concentraton determined by a new and specific assay. , 1980, American heart journal.
[7] E Besterman,et al. Waller--pioneer of electrocardiography. , 1979, British heart journal.
[8] D. Zipes,et al. Atrial induction of ventricular tachycardia: reentry versus triggered automaticity. , 1979, The American journal of cardiology.
[9] S. Bryson,et al. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability. , 1978, British journal of clinical pharmacology.
[10] A. Adgey,et al. Long-term oral antiarrhythmic therapy with mexiletine. , 1978, Postgraduate medical journal.
[11] Y. Latour,et al. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. , 1977, Annals of internal medicine.
[12] J. Koch-weser,et al. Procainamide dosage schedules, plasma concentrations, and clinical effects. , 1971, JAMA.
[13] L. Dreifus,et al. Comparative mechanisms of antiarrhythmic agents. , 1970, The American journal of cardiology.
[14] D C Harrison,et al. Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. , 1967, The New England journal of medicine.
[15] M. Sokolow,et al. Factors Influencing Conversion of Chronic Atrial Fibrillation with Special Reference to Serum Quinidine Concentration , 1956, Circulation.
[16] M. Leider. Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .
[17] A. L. Wit. Electrophysiological basis for antiarrhythmic drug action. , 1985, Clinical physiology and biochemistry.
[18] H. Snellen. Willem Einthoven Memorial Symposium on Developments in Electrocardiography 1927-1977, Leiden, The Netherlands, 28 October 1977. Introduction. , 1978, European journal of cardiology.
[19] J. Clements,et al. Absorption, distribution and elimination of mexiletine. , 1977, Postgraduate medical journal.